Published in Phytopathology on December 01, 2003
Delimitation of Neonectria and Cylindrocarpon (Nectriaceae, Hypocreales, Ascomycota) and related genera with Cylindrocarpon-like anamorphs. Stud Mycol (2011) 1.29
Neonectria liriodendri sp. nov., the main causal agent of black foot disease of grapevines. Stud Mycol (2006) 1.16
American ginseng: research developments, opportunities, and challenges. J Ginseng Res (2011) 0.85
Direct Detection of Cylindrocarpon destructans, Root Rot Pathogen of Ginseng by Nested PCR from Soil Samples. Mycobiology (2010) 0.79
Genetic Diversity and Pathogenicity of Cylindrocarpon destructans Isolates Obtained from Korean Panax ginseng. Mycobiology (2014) 0.79
Characterization of five fungal endophytes producing Cajaninstilbene acid isolated from pigeon pea [Cajanus cajan (L.) Millsp]. PLoS One (2011) 0.75
Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science (1995) 6.58
A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell (2000) 6.14
DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. J Virol (1979) 2.63
Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect Immun (1996) 2.50
Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome (1997) 2.47
Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet (2000) 2.24
The IGF system and breast cancer. Endocr Relat Cancer (2001) 2.21
Forkhead homologue in rhabdomyosarcoma functions as a bifunctional nuclear receptor-interacting protein with both coactivator and corepressor functions. J Biol Chem (2001) 2.07
Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol (1999) 2.00
Phylogeny and nomenclature of the genus Talaromyces and taxa accommodated in Penicillium subgenus Biverticillium. Stud Mycol (2011) 1.98
Electroporation: parameters affecting transfer of DNA into mammalian cells. Anal Biochem (1987) 1.94
An overview of the taxonomy, phylogeny, and typification of nectriaceous fungi in Cosmospora, Acremonium, Fusarium, Stilbella, and Volutella. Stud Mycol (2011) 1.83
Genetic deletion of a neural cell adhesion molecule variant (N-CAM-180) produces distinct defects in the central nervous system. Neuron (1993) 1.74
Fungal Planet description sheets: 69-91. Persoonia (2011) 1.71
FKHR binds the insulin response element in the insulin-like growth factor binding protein-1 promoter. Endocrinology (1999) 1.61
Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res (1990) 1.57
Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res (1997) 1.54
Sensitivity and selectivity in protein similarity searches: a comparison of Smith-Waterman in hardware to BLAST and FASTA. Genomics (1996) 1.53
Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines. Oncogene (2001) 1.51
The prevalence and nature of podiatric problems in elderly diabetic patients. J Am Geriatr Soc (1991) 1.49
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells. Br J Cancer (2006) 1.49
Microcoding: the second step in DNA barcoding. Philos Trans R Soc Lond B Biol Sci (2005) 1.41
Insulin-like growth factor I-induced degradation of insulin receptor substrate 1 is mediated by the 26S proteasome and blocked by phosphatidylinositol 3'-kinase inhibition. Mol Cell Biol (2000) 1.38
Insulin-like growth factor (IGF)-I rescues breast cancer cells from chemotherapy-induced cell death--proliferative and anti-apoptotic effects. Breast Cancer Res Treat (1999) 1.33
The albino-deletion complex in the mouse defines genes necessary for development of embryonic and extraembryonic ectoderm. Development (1989) 1.32
Treatment with 24-epibrassinolide, a brassinosteroid, increases the basic thermotolerance of Brassica napus and tomato seedlings. Plant Mol Biol (1999) 1.32
Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J Biol Chem (1998) 1.29
Self-concepts, domain values, and self-esteem: relations and changes at early adolescence. J Pers (1989) 1.26
Lignin degradation by Phanerochaete chrysosporium in hyperbaric oxygen. Can J Microbiol (1980) 1.24
Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation. Oncogene (2010) 1.23
The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene (2009) 1.20
Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol (1997) 1.19
A taxonomic and phylogenetic revision of the Penicillium sclerotiorum complex. Stud Mycol (2011) 1.19
Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. Breast Cancer Res (2000) 1.16
Elevated levels of p66 Shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Cancer Res (2000) 1.13
Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst (1996) 1.10
The role of p21 in interferon gamma-mediated growth inhibition of human breast cancer cells. Cell Growth Differ (2000) 1.10
Cloning, chromosome localization, expression, and characterization of an Src homology 2 and pleckstrin homology domain-containing insulin receptor binding protein hGrb10gamma. J Biol Chem (1997) 1.09
Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst (1992) 1.09
Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms. Genomics (2001) 1.08
Sequence tag analysis of gene expression during pathogenic growth and microsclerotia development in the vascular wilt pathogen Verticillium dahliae. Fungal Genet Biol (2003) 1.08
Phosphorylation and nuclear exclusion of the forkhead transcription factor FKHR after epidermal growth factor treatment in human breast cancer cells. Oncogene (2000) 1.07
Monilochaetes and allied genera of the Glomerellales, and a reconsideration of families in the Microascales. Stud Mycol (2011) 1.07
Nucleotide sequence and transcription of a bacteriophage 29 early promoter. J Biol Chem (1985) 1.06
The albino deletion complex and early postimplantation survival in the mouse. Development (1988) 1.04
Description and DNA barcoding of three new species of Leohumicola from South Africa and the United States. Persoonia (2008) 1.04
Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res (1998) 1.03
New penicillin-producing Penicillium species and an overview of section Chrysogena. Persoonia (2012) 1.03
Insulin-like growth factors and breast cancer. Biomed Pharmacother (1995) 1.01
Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Lab Invest (1989) 0.99
Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem (1993) 0.97
A revision of Cyanonectria and Geejayessia gen. nov., and related species with Fusarium-like anamorphs. Stud Mycol (2011) 0.96
The insulin-like growth factors, their receptors, and their binding proteins in human breast cancer. Cancer Treat Res (1991) 0.96
IGF system components as prognostic markers in breast cancer. Breast Cancer Res Treat (1998) 0.94
Strain-specific differences in formation of apoptotic DNA ladders in MCF-7 breast cancer cells. Cancer Lett (1999) 0.94
Third nerve palsy: superior oblique transposition surgery. Ann Ophthalmol (1973) 0.94
Mechanistic studies on deoxyribonucleic acid dependent ribonucleic acid polymerase from Escherichia coli using phosphorothioate analogues. 2. The elongation reaction. Biochemistry (1979) 0.93
Insulinlike growth factors in human malignancy. Cancer Invest (1991) 0.93
Proliferation of cultured human prostate cancer cells is inhibited by insulin-like growth factor (IGF) binding protein-1: evidence for an IGF-II autocrine growth loop. J Clin Endocrinol Metab (1995) 0.93
The chromosomal location of mouse interferon alpha genes. EMBO J (1984) 0.93
Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore. Br J Cancer (2009) 0.93
Mechanistic studies on deoxyribonucleic acid dependent ribonucleic acid polymerase from Escherichia coli using phosphorothioate analogues. 1. Initiation and pyrophosphate exchange reactions. Biochemistry (1979) 0.92
Introduction: IGFs and IGFBPs in the normal mammary gland and in breast cancer. J Mammary Gland Biol Neoplasia (2000) 0.91
A novel human insulin-like growth factor I messenger RNA is expressed in normal and tumor cells. Mol Endocrinol (1990) 0.90
Inhibition of estrogen-induced breast cancer cell proliferation by reduction in autocrine transforming growth factor alpha expression. Cell Growth Differ (1994) 0.90
Characterization of insulin-like growth factor-I and its receptor and binding proteins in transected nerves and cultured Schwann cells. J Neurochem (1996) 0.90
Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells. J Cell Physiol (1993) 0.89
Regulation of human breast cancer by secreted growth factors. Acta Oncol (1989) 0.89
IRS-1 expression and activation are not sufficient to activate downstream pathways and enable IGF-I growth response in estrogen receptor negative breast cancer cells. Growth Horm IGF Res (1999) 0.89
Assignment of the gene for beta 2-microglobulin (B2m) to mouse chromosome 2. Proc Natl Acad Sci U S A (1982) 0.88
Polyethylene glycol conjugated insulin-like growth factor binding protein-1 (IGFBP-1) inhibits growth of breast cancer in athymic mice. Eur J Cancer (1997) 0.88
Case management for frail elders: the Robert Wood Johnson Foundation's Program for Hospital Initiatives in Long-Term Care. Gerontologist (1989) 0.88
Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. Brain Res Mol Brain Res (1992) 0.87
Insulin-like growth factors in human breast cancer. Breast Cancer Res Treat (1991) 0.87
Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivo. Horm Metab Res (2004) 0.87
Fungal Planet description sheets: 128-153. Persoonia (2012) 0.87
Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II). Eur J Cancer (1993) 0.87
The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res Treat (1992) 0.86
A protein required for RNA processing and splicing in Neurospora mitochondria is related to gene products involved in cell cycle protein phosphatase functions. Proc Natl Acad Sci U S A (1992) 0.86
Reducing methylmercury accumulation in the food webs of San Francisco Bay and its local watersheds. Environ Res (2012) 0.85
Complement activation involvement in decompression sickness of rabbits. Undersea Biomed Res (1990) 0.85
Stem cell deficiencies and thymic abnormalities in fetal mouse trisomy 16. J Exp Med (1985) 0.85
Schools, families, and early adolescents: what are we doing wrong and what can we do instead? J Dev Behav Pediatr (1996) 0.85
Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett (1994) 0.85
A high density COX1 barcode oligonucleotide array for identification and detection of species of Penicillium subgenus Penicillium. Mol Ecol Resour (2009) 0.84
The insulin-like growth factor family of ligands, receptors, and binding proteins. Breast Cancer Res Treat (1992) 0.84
Application of machine learning methodology for PET-based definition of lung cancer. Curr Oncol (2010) 0.84
Gene expression of the insulin-like growth factors and their receptors in human neuroblastoma cell lines. Brain Res Mol Brain Res (1992) 0.83
Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen. Eur J Cancer (1993) 0.83
Quality-of-life outcomes in high-risk prostate cancer patients treated with helical tomotherapy in a hypofractionated radiation schedule with long-term androgen suppression. Curr Oncol (2012) 0.82
Prognostic indicators in early breast cancer. Am J Med Sci (1993) 0.82
Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines. Br J Cancer (1998) 0.82
Characterization of insulin-like growth factor binding proteins and regulation of IGFBP3 in human mesangial cells. Kidney Int (1996) 0.81
Secondary metabolites of Penicillium bilaii strain PB-50. Mycopathologia (1994) 0.81
In vitro sensitivity testing of human bladder cancers and cell lines to TP-40, a hybrid protein with selective targeting and cytotoxicity. J Urol (1993) 0.81
Lac repressor inducible gene expression in human breast cancer cells in vitro and in a xenograft tumor. Biotechniques (1997) 0.81
SSLPs to map genetic differences between the 129 inbred strains and closed-colony, random-bred CD-1 mice. Mamm Genome (1997) 0.80
Short-term rescue by RNA injection of a mitotic arrest mutation that affects the preimplantation mouse embryo. Dev Biol (1987) 0.80
Influences of Cropping Practices on Verticillium dahliae Populations in Commercial Processing Tomato Fields in Ontario. Phytopathology (2000) 0.79
Identification of NephrotoxicPenicillium Species from Cereal Grains. Mycotoxin Res (1995) 0.79